Cargando…

Effects of Dopamine on Sensitivity to Social Bias in Parkinson's Disease

Patients with Parkinson's disease (PD) sometimes develop impulsive compulsive behaviours (ICBs) due to their dopaminergic medication. We compared 26 impulsive and 27 non-impulsive patients with PD, both on and off medication, on a task that examined emotion bias in decision making. No group dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Djamshidian, Atbin, O'Sullivan, Sean S., Lees, Andrew, Averbeck, Bruno B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298454/ https://www.ncbi.nlm.nih.gov/pubmed/22427905 http://dx.doi.org/10.1371/journal.pone.0032889

Ejemplares similares

Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
por: Djamshidian, Atbin, et al.
Publicado: (2011)

Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's Disease
por: Djamshidian, Atbin, et al.
Publicado: (2015)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
por: Heim, Beatrice, et al.
Publicado: (2023)

Effects of Dopamine Medication on Sequence Learning with Stochastic Feedback in Parkinson's Disease
por: Seo, Moonsang, et al.
Publicado: (2010)

The prevalence of impulsive compulsive behaviors in patients treated with apomorphine infusion: a retrospective analysis
por: Barbosa, Pedro, et al.
Publicado: (2021)

Differentiating Parkinson’s Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis
por: Heim, Beatrice, et al.
Publicado: (2022)

Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease?
por: Stockner, Heike, et al.
Publicado: (2012)

Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases
por: De Pablo-Fernandez, Eduardo, et al.
Publicado: (2015)

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson’s Disease
por: Peball, Marina, et al.
Publicado: (2023)

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
por: Peball, Marina, et al.
Publicado: (2022)

Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year Study
por: Marini, Kathrin, et al.
Publicado: (2021)

Association between hearing sensitivity and dopamine transporter availability in Parkinson’s disease
por: Garasto, Elena, et al.
Publicado: (2023)

Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson’s disease
por: Muhammed, Kinan, et al.
Publicado: (2016)

Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
por: Ellmerer, Philipp, et al.
Publicado: (2022)

Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
por: Peball, Marina, et al.
Publicado: (2019)

Reflection impulsivity perceptual decision‐making in patients with restless legs syndrome
por: Heim, Beatrice, et al.
Publicado: (2018)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population‐Based Cohort
por: Marini, Kathrin, et al.
Publicado: (2020)

Real-Time Dopamine Measurement in Awake Monkeys
por: Schluter, Erik W., et al.
Publicado: (2014)

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)

Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
por: Eckhardt, Christine, et al.
Publicado: (2022)

Hospital Admissions of Huntington's Disease Patients in a Huntington's Disease Centre Between 2011 and 2016: A Retrospective Analysis
por: Peball, Marina, et al.
Publicado: (2022)

Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study
por: Poewe, Werner, et al.
Publicado: (2021)

The effects of dopamine on digit span in Parkinson’s disease
por: Warden, Clara, et al.
Publicado: (2016)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Impaired dopamine release in Parkinson’s disease
por: Cramb, Kaitlyn M L, et al.
Publicado: (2023)

Parkinson's Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response
por: Hudson, Craig J., et al.
Publicado: (2014)

Decision making and framing effects in multiple sclerosis
por: Zamarian, Laura, et al.
Publicado: (2020)

Effects of Dopamine Depletion on Network Entropy in the External Globus Pallidus
por: Cruz, Ana V., et al.
Publicado: (2009)

Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
por: Grogan, John P, et al.
Publicado: (2017)

Medication Timing Errors for Parkinson's Disease: Perspectives Held by Caregivers and People with Parkinson's in New Zealand
por: Buetow, Stephen, et al.
Publicado: (2009)

Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson’s disease
por: van der Vegt, Joyce P.M., et al.
Publicado: (2020)

Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
por: Park, Ariane, et al.
Publicado: (2011)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017)

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
por: Masato, Anna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5h7r2qtnbots1qra7bpmelhplf